BTI - British American Tobacco p.l.c.

NYSE - NYSE Delayed Price. Currency in USD
-0.39 (-0.95%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
  • Short Term
    2W - 6W
  • Mid Term
    6W - 9M
  • Long Term
Previous Close40.98
Bid40.02 x 1000
Ask40.65 x 4000
Day's Range40.59 - 41.19
52 Week Range27.32 - 45.64
Avg. Volume2,629,676
Market Cap91.422B
Beta (5Y Monthly)0.68
PE Ratio (TTM)1.83
EPS (TTM)22.16
Earnings DateN/A
Forward Dividend & Yield2.71 (6.61%)
Ex-Dividend DateJul 09, 2020
1y Target Est51.34
  • British American Tobacco's COVID-19 Vaccine May Enter Trials
    Motley Fool

    British American Tobacco's COVID-19 Vaccine May Enter Trials

    Tobacco vaccine production is a surprisingly economical endeavor, saving time and costs. Kentucky Bioprocessing, the biotechnology subsidiary of British American Tobacco, is leading the way.

  • This Trio of Graham-Style Stocks Appears to Be Reasonably Priced

    This Trio of Graham-Style Stocks Appears to Be Reasonably Priced

    Exxon Mobil tops the list Continue reading...

  • Is British American Tobacco Stock a Buy?
    Motley Fool

    Is British American Tobacco Stock a Buy?

    British American Tobacco (NYSE: BTI) is a London-based company, but its acquisition of Reynolds American in 2017 gave BAT the No. 2 position in U.S. cigarette market share. At this point, BAT's declines have made it look especially attractive to value investors, but prospective buyers want to know whether they're getting themselves into a value trap. Below, we'll look more closely at British American Tobacco and whether its stock is a good buy.

  • Is British American Tobacco (BTI) a Great Value Stock Right Now?

    Is British American Tobacco (BTI) a Great Value Stock Right Now?

    Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

  • Will Cigarette Companies Save Us From COVID-19?
    Motley Fool

    Will Cigarette Companies Save Us From COVID-19?

    Although there are many companies pursuing a vaccine for COVID-19, the tobacco industry may be one of the more surprising combatants in this battle. Both British American Tobacco (NYSE: BTI) and Philip Morris International (NYSE: PM) are working on a vaccine for the disease. Unlike automakers or cosmetics companies converting production facilities to make personal protective equipment, it's not the actual manufacturing units of the tobacco companies working to fight COVID-19, but rather their biotech divisions.

  • Philip Morris, Altria Are Facing ITC Investigations; What Should Investors Know?
    Motley Fool

    Philip Morris, Altria Are Facing ITC Investigations; What Should Investors Know?

    The U.S. International Trade Commission has announced a probe into Altria and Philip Morris for alleged patent violations over iQOS heat-not-burn technology.

  • 7 Sin Stocks To Buy During The Coronavirus Shutdown

    7 Sin Stocks To Buy During The Coronavirus Shutdown

    There's no question Americans are facing unprecedented stresses these days. Data suggests some Americans are relying on vices such as alcohol, tobacco and cannabis to get through the health crisis. At the same time, gamblers have been driven online for the time being due to casino closures.When times are good, people like to celebrate with a drink or a smoke or a roll of the dice. When times are hard, they turn to these activities as a distraction or a means of self-medication. Regardless of how you feel about the activities themselves, here are seven "sin stocks" to buy that Morningstar analysts say have significant upside.Philip Morris International Inc. (NYSE: PM)Philip Morris is one of the largest global tobacco companies and holds nearly a 30% market share of the international cigarette and heated tobacco markets.Analyst Philip Gorham says Marlboro customer loyalty is extremely high and Philip Morris has considerable pricing power. The company has a first-mover advantage in heated tobacco, but it remains to be seen whether or not heated tobacco can completely offset lost cigarette volumes over time. Gorham says a successful launch of iQOS in the U.S. would generate completely incremental revenue given the company currently has no U.S. products.Philip Morris shares also pay a sizable 6.9% dividend.Morningstar has a Buy rating and $98 price target for PM stock.See Also: 7 Best Cheap Stocks To Buy Or Sell Cronos Group Inc (NASDAQ: CRON)Cronos is one of the "big four" Canadian legal producers of cannabis and owner of brands such as PEACE NATURALS, COVE and Lord Jones. Cronos reported impressive 180% revenue growth in the first quarter, but it also reported a $45 million operating loss.Analyst Kristoffer Inton says write-downs associated with lower prices due to oversupply in the Canadian market were the cause of the loss. However, Inton says Cronos' write-downs are shrinking, whereas other cannabis producers' losses are growing. Morningstar is projecting Canadian cannabis demand will grow 20% annually over the next decade, and Cronos has the balance sheet to expand its market share.Morningstar has a Buy rating and $8.50 fair value estimate for CRON stock.Las Vegas Sands Corp. (NYSE: LVS)Las Vegas Sands is an international casino operator that owns casino resorts and hotels in Las Vegas, Macau and Singapore. Analyst Dan Wasiolek says Macau and Singapore are the keys to the bull case for Las Vegas Sands.Macau accounted for about 59% of Sands' earnings in 2019, and Singapore was another 31%. Wasiolek says Sand's has a dominant position in the high-growth Cotai Strip in Macau, and it has a duopoly in place in Singapore through at least 2030. COVID-19 shutdowns in Las Vegas and a 97% drop in gross gaming revenue due to COVID-19 may be scary, but Wasiolek estimates Las Vegas sands has 18 months of liquidity at nearly zero revenue.Mornigstar has a Buy rating and $62 fair value estimate for LVS stock.British American Tobacco PLC (NYSE: BTI)British American Tobacco is an international tobacco company that owns brands such as Lucky Strike, Newport and Camel and generates 45% of its revenue from the U.S. market.While cigarette volumes are likely in secular decline, Gorham says British American's accelerated volume declines in fiscal 2019 may be particularly troubling to investors. However, he says the company may be best-positioned to capitalize on the next generation of tobacco products, including its Vype and Vuse vaping brands an Glo heated tobacco brand. Gorham says British American's buyout of Reynolds American was a solid strategic move given its pricing power and the value of its assets.Morningstar has a Buy rating and $59 target for BTI stock.Anheuser Busch Inbev NV (NYSE: BUD)Anheuser Busch Inbev is the world's largest brewer and owner of brands such as Budweiser, Beck's and Corona.Gorham says the worst of the downturn may be yet to come for Anheuser Busch, but the company has plenty of liquidity to navigate the crisis. In the longer term, he says the company's near monopoly and cost advantages in developed markets make the stock a solid investment, and its potential for free cash flow generation isn't fully priced in at current levels. Gorham projects volumes will fall 20% in the first half of 2020 and only 7% in the second half of the year.Morningstar has a Buy rating and $96 fair value estimate for BUD stock.Altria Group Inc (NYSE: MO)Altria Group is one of the world's largest tobacco companies, but it's also one of the most diversified sin stocks. In addition to being the parent company of Philip Morris USA, Altria has a more than 10% ownership stake in Anheuser Busch, a 35% stake in vaping leader JUUL, and a 45% stake in cannabis stock Cronos.Gorham says COVID-19 has certainly disrupted Altria's business, but its underlying business trends in the first quarter appear to be solid. Cigarette shipment volume was up 6%, and management reiterated its guidance that industry-wide volume will drop between 4% and 6% this year.Morningstar has a Buy rating and $54 fair value estimate for MO stock.See Also: 7 Best-Performing Stocks Of 2020: Buy, Sell Or Hold?Constellation Brands, Inc. (NYSE: STZ)Constellation Brands is one of the world's largest producers of wine, spirits and imported beer and owns brands such as Arbor Mist, Black Velvet and SVEDKA. Constellation also recently upped its ownership stake in leading Canadian cannabis producer Canopy Growth Corp (NYSE: CGC) to nearly 40%.Analyst Nicholas Johnson says Constellation's beer business should help support numbers for now, and the sell-off in the stock has pushed it to "egregiously cheap" levels. In fact, given his bullish long-term outlook for Constellation, Johnson says it's his top stock pick in the pure-play beverage group.Morningstar has a Buy rating and $215 price target for STZ stock.Latest Ratings for CRON DateFirmActionFromTo May 2020StifelMaintainsHold Apr 2020Piper SandlerDowngradesOverweightNeutral Apr 2020B of A SecuritiesDowngradesBuyNeutral View More Analyst Ratings for CRON View the Latest Analyst RatingsSee more from Benzinga * Here's How Much Investing 0 In The 2018 Cronos Listing Would Be Worth Today * The Road To Recovery For Las Vegas Casino Stocks * Cannabis Stock Rally Puts Short Sellers In The Red For 2020(C) 2020 Benzinga does not provide investment advice. All rights reserved.

  • U.S. Cases Increase 2%; New York Beaches to Reopen: Virus Update

    U.S. Cases Increase 2%; New York Beaches to Reopen: Virus Update

    (Bloomberg) -- New York is joining other Atlantic coast states in allowing beaches to reopen in time for the U.S. Memorial day holiday. Italy had the fewest new coronavirus cases in four days as it prepares to let citizens move freely starting in June.Abbott Laboratories fell after the U.S. Food and Drug Administration said a company test for Covid-19 used by the White House has potential accuracy issues. Cigarette maker British American Tobacco is poised to begin testing an experimental vaccine in humans.The cost of the pandemic could reach as high as $8.8 trillion, the Asian Development Bank said. The German economy shrank the most in more than a decade, offering an early flavor of the damage, while U.S. retail sales plunged in April.Key Developments:Virus Tracker: Cases top 4.5 million; deaths reach 306,000Trump introduces “warp speed” leaders on vaccineU.S. warns Abbott’s virus test has potential accuracy issuesEmpty Times Square rooms signal reckoning for hotelsFarms, ranches seek billions in aid as losses mountVirus revives worst-case scenarios for U.S.-China relationsEating out in London will never be the same againSubscribe to a daily update on the virus from Bloomberg’s Prognosis team here. Click VRUS on the terminal for news and data on the coronavirus. See this week’s top stories from QuickTake here.Trump Seeks to Force Hospitals to Open Books (5:55 p.m. NY)The White House wants Congress to require hospitals and insurers to reveal the prices they negotiate for medical services as part of the next round of coronavirus stimulus, in an effort to short-circuit a legal battle with the health care industry.The U.S. Health and Human Services department published two regulations last year requiring the prices be made public. The industry challenged the rule in court arguing it’s violates the First Amendment, and delayed its implementation. The White House believes making it a law would end the matter, according to people familiar with the matter.N.Y. Tax Revenue Fell 68% in April (5:40 p.m. NY)New York state’s tax revenue plummeted 68.4% in April, as the lockdowns and the extension of tax return filings to July 15 took a toll. It collected $3.7 billion, or $7.9 billion less than the previous April. Personal income-tax revenue fell more than $7 billion from last April, a drop that was primarily due to the delayed tax filing deadline.“New York is facing economic devastation not seen since the Great Depression,” New York Comptroller Thomas DiNapoli said in a news release. “New York and other hard-hit states need the federal government to step up and provide assistance, or the state will have to take draconian actions to balance its budget.”Portual Set to Reopen Beaches (4:50 p.m. NY)Portugal plans to reopen beaches popular with tourists on June 6 as the government eases confinement measures and adopts new rules to keep 1.5 meters (5 feet) between people, Prime Minister Antonio Costa said at a Lisbon news conference. Signs will show the crowd size at any beach, and some may close if too many people congregate. Tourism, including on Portugal’s Atlantic coast, accounts for about 15% of the economy and 9% of employment.NIH Director, Labor Secretary Join Task Force (4:30 p.m. NY)U.S. National Institutes of Health Director Francis Collins and Labor Secretary Gene Scalia are among five new appointees to the White House coronavirus task force, which Vice President Mike Pence said is focusing on getting U.S. business reopened. Pence, the chairman, also added Agriculture Secretary Sonny Perdue to the 23-member group along with Peter Marks, director of the Food and Drug Administration’s Center for Biologics Evaluation and Research; and Thomas Engels, administrator of the Health Resources and Services Administration.Fed Warns of Asset Price Plunge (4:15 p.m. NY)The Federal Reserve in a stark warning said stock and other asset prices could suffer “significant declines” should the pandemic deepen, with commercial real estate being among the hardest-hit.The Fed’s twice-yearly financial stability report flagged risks to the banking system and broader economy and highlighted its race to intervene in markets and temporarily dial back rules on financial firms amid the outbreak.The abrupt shutdown of economies triggered market uncertainty that upended trading from Treasury securities to junk bonds and led to dramatic swings in prices. Markets settled as the Fed flooded the financial system with liquidity.U.S. Cases Rise 2%, Above Week Average (4 p.m. NY)Coronavirus cases in the U.S. increased 2% compared with the same time Thursday to 1.43 million, according to data collected by Johns Hopkins University and Bloomberg News. The increase was above the average daily increase of 1.7% over the past week. Deaths rose 2% to 86,744.New York had 132 deaths, according to Governor Andrew Cuomo. That marked the state’s fifth straight day of deaths below 200 and the first time deaths fell below 150 in seven weeks.In New Jersey, deaths increased by 201 to 10,138, a 2% increase over 24 hours. New cases rose 1% to 143,905, according to Governor Phil Murphy.Florida reported 44,138 cases, up 2.1% from a day earlier, according to the state’s health department. Deaths rose 2.4% to 1,197.California’s cases rose 2.4% to 74,936 while deaths rose 2.5% to 3,108, according to the state’s website.Spain Advances Reopening for 70% of Nation (3:25 p.m. NY)Spain put about 70% of the nation’s population into the second phase of a four-step reopening process, Health Minister Salvador Illa said. Madrid and Barcelona, the nation’s two biggest cities, will remain in the restrictive first phase, he said. Certain rules also are being eased, such as allowing shops to operate without the need for appointments, but Illa said limits will remain on the number of employees per client.Mall of America to Reopen June 1 (2:20 p.m. NY)Minnesota’s sprawling Mall of America will reopen June 1, two weeks after the state allowed on-site retail to resume. The mall, which got 40 million annual visitors before the pandemic, said tenants need time to rehire and train staff as well as clean, sanitize and take safety measures. When open, the 2.5-million-square-foot mall near Minneapolis will limit customers to 50% of capacity. Restaurants and play areas will stay closed until state officials approve.Florida Allows Gyms to Reopen (1:28 p.m NY)Florida gyms can reopen, and retailers and restaurants will be able to operate at 50% indoor capacity, up from 25%, starting Monday, Governor Ron DeSantis said.The state started reopening last week, with DeSantis saying the Sunshine State had dodged the worst-case scenarios predicted by some analysts. He said Friday that ventilator use and Covid-19 patients in intensive-care units have both declined significantly since the start of Florida’s stay-at-home order.“The American people never signed up for a perpetual shelter in place,” DeSantis said.N.J. Virus Deaths Top 10,000 (1:15 p.m. NY)New Jersey deaths from the new coronavirus topped 10,000, days before the state takes steps toward reopening. The toll belies improvements in hospitalization and other data that have led Governor Phil Murphy to take some steps toward restarting the state’s economy. Total hospitalizations are about half of the peak, while patients on ventilators and in intensive care also have dropped.Air France-KLM Reverses, Offers Refunds (12:40 p.m. NY)Air France-KLM will offer refunds to customers whose flights were canceled by the pandemic, a policy reversal that could add pressure on the struggling carrier’s balance sheet. Travelers will get a cash reimbursement or a voucher for a future flight worth 15% more than the initial ticket value, according to a statement. The incentive is to encourage customers to opt for future flights.Through March 31, the value of tickets for flights that may be canceled and for which the airline could be liable for vouchers or refunds reached about 2 billion euros ($2.2 billion), according to the carrier.WHO Pushes Vaccine Access Plan (12:30 p.m. NY)The World Health Organization is pushing a proposal that aims to ensure broad access to Covid-19 treatments and vaccines while offering an appropriate reward to creators.Under the plan offered by Costa Rica, drug companies would voluntarily donate Covid-related intellectual property to a global pool. Countries would be free to decide how to mete out the rights.Countries would retain the right to allow low-cost generics of patented medicines. WHO Director-General Tedros Adhanom Ghebreyesus is urging countries and companies to support the proposal, which will be discussed Monday and Tuesday.Italy Has Fewest Cases in Four Days (12:05 p.m. NY)Italy registered the fewest new cases in four days, as the government considers letting citizens move freely starting on June 3 after more than two months of lockdown.Civil protection authorities reported 789 cases compared with 992 a day earlier, bringing the total to 223,885. Daily fatalities fell to 242 from 262 on Thursday, for a total of 31,610.N.Y. Joins N.J. to Reopen Beaches (11:50 a.m. NY)New York Governor Andrew Cuomo said city, town and county beaches may open in time for the Memorial Day holiday weekend, with group-contact activities like volleyball prohibited. Occupancy will be limited to 50% capacity, the governor said.New Jersey on Thursday announced it would open its beaches for the holiday, and Delaware also is opening. Cuomo said he understands that if New York doesn’t open facilities, residents will just flock to neighboring states.New York had 132 new deaths, the first time the total fell below 150 in seven weeks.Navy Hospital Ship Leaves L.A. (11:40 a.m. NY)The U.S. Navy hospital ship Mercy has left Los Angeles, ending a seven-week deployment aimed at easing the burden on the region’s medical system, U.S. Northern Command said. About 60 personnel will remain to work at skilled nursing facilities, according to a statement. Mercy docked at the Port of Los Angeles on March 27. The USNS Comfort spent April in New York City on a similar mission.Another Brazil Health Chief Leaves (11:30 a.m. NY)Brazil’s health minister quit the post less than a month after his predecessor was fired by President Jair Bolsonaro amid a clash over social distancing steps. Nelson Teich stepped down on Friday, the government said.The Health Ministry reported 13,944 new cases on Thursday, solidifying the nation as the new global hot spot. Infections more than doubled in the past two weeks, pushing the total to 202,918.NYC, Long Island Lockdowns Extended (11:15 a.m. NY)New York City, Long Island and three other regions have failed to meet requirements for reopening, and as a result their lockdowns will remain in effect for at least two more weeks. Five upstate regions -- the Finger Lakes, Central New York, Mohawk Valley, Southern Tier and North Country -- met the criteria, according to an executive order signed Thursday night. New York, Long Island and Western New York met four of seven metrics, while the Capital and Mid-Hudson regions met five. The metrics include requirements for hospital-bed capacity, testing and tracing.Austria to Resume Cultural Events (10:50 a.m. NY)Austria, one of the first countries to ease its lockdown, will allow cultural events again, restarting an important part of its tourism industry. Events with as many as 100 people will be allowed from May 29, rising to 250 in July, when cinemas will reopen as well, and to 1,000 in August. The Salzburg Festival, a major draw for an audience including CEOs and heads of state, will take place in a scaled-down version.U.K. Pubs Dump 70 Million Pints (10:30 a.m. NY)U.K. pubs shut since late March may be forced to dump 70 million pints of beer -- enough to fill more than 16 Olympic-sized swimming pools -- because much of the brew in storage will spoil before reopening in early July, the British Beer and Pub Association said. Some of the unsold beer is being used as feed for anaerobic digesters to create organic fertilizer for farming, the group said.Portugal’s Hospitalized Cases Drop (8:47 a.m. NY)Since Portugal started easing confinement measures on May 4, the number of hospitalized patients has dropped by more than 17%, while cases in intensive care units have declined 16%. Portugal reported 264 new confirmed coronavirus cases on Friday, up from 187 on Thursday, taking the total to 28,583, the government said. The total number of deaths rose by 6 to 1,190.Denmark Records No Virus Deaths (8:42 a.m. NY)The Nordic nation had its first day without Covid-19 related deaths in since mid-March, evidence that its strategy of locking down early has succeeded in bringing the virus under control. The number of deaths was unchanged at 537 on Friday, health authorities in Copenhagen said.Switzerland Opens Borders to Germany, Austria (8:31 a.m. NY)All closed Swiss border crossings will be reopened by the first half of next week in coordination with Germany and Austria, Christian Bock, director at the Swiss Federal Customs Administration, told reporters in Bern.U.S. Retail Sales Post Record Decline (8:30 a.m. NY)U.S. retail sales plunged by the most on record for a second month as the pandemic shuttered businesses, spurred layoffs and kept Americans at home. Revenue at retailers and restaurants fell 16.4% in April from the prior month, worse than the 8.3% drop in March -- previously the worst in data back to 1992.Separately, a gauge of factory activity in New York State shrank in May. The Federal Reserve Bank of New York’s general business conditions index improved to minus 48.5 from an all-time low of minus 78.2 in April, a report out Friday showed.Abbott Labs Slides in Testing Fracas (7:54 a.m. NY)Abbott Labs slipped 3% pre-market on Friday after the FDA issued a warning on possible accuracy issues with the devicemaker’s ID Now test for Covid-19 infections. Quidel, the maker of a competing test, rose 2.8%.“Although it remains to be seen if there are repercussions from this study’s results, the headlines come at a time when new rival tests are coming online, including QDEL’s rapid antigen Sofia,” JPMorgan analysts led by Tycho Peterson wrote.North Face Owner VF Sees Sales Slump (7:52 a.m. NY)VF Corp., whose stable of brands includes Vans and the North Face, expects first-quarter sales to fall by more than half as the coronavirus outbreak upends the retail sector. The shares fell in early trading.The company said it couldn’t estimate the impact of the Covid-19 pandemic beyond the coming quarter, joining a growing list of companies pulling their financial forecasts for the year. Sales and profit in the fiscal fourth quarter, which ended March 28, both missed Wall Street’s estimates.“Through the first ten months of fiscal 2020 our business delivered results above our stated long-term growth objectives,” Chief Executive Officer Steve Rendle said in a statement. “Then the world changed for all of us as a result of Covid-19.”Fiat Seeks $6.8 Billion State-Backed Loan (7:40 a.m. NY)Fiat Chrysler Automobiles NV is in talks to obtain a state-backed credit line of about 6.3 billion euros ($6.8 billion) to strengthen the carmaker’s financial buffer against the steep downturn caused by the coronavirus, according to people familiar with the matter.Fiat’s local unit is discussing the facility with Intesa Sanpaolo SpA, which is the lead lender, the people said, asking not to be named because the matter is private. Sace SpA, Italy’s trade-credit insurer, will provide a public guarantee for 80% of the amount, they said.The guarantee would need to be granted by a decree of the Finance Ministry, the people added.Orban May Give Up Special Powers at End-May (7:30 a.m. NY)Hungary’s Prime Minister Viktor Orban said he may be able to give up special powers granted to him by parliament to fight the coronavirus pandemic at the end of May, according to the state news service MTI. Orban’s comments, reported from a press briefing in Serbia, bring forward the end to a potentially indefinite state of emergency announced in March. The move triggered European Union criticism about whether he was using the pandemic as pretext for a power grab.A Third of U.K. Workers Deemed Vital (7:25 a.m. NY)One in three U.K. workers are in jobs deemed vital during the coronavirus lockdown, and many of them are at heightened risk of contracting the disease. The Office for National Statistics said Friday there were 10.6 million so-called key workers last year and 15% of them are at moderate risk from Covid-19 because of a health condition such as asthma, heart disease and diabetes.The findings are likely to renew calls to improve pay and conditions for those on the front line in the battle against the pandemic, who in general earn less than employees in other occupations. The Institute for Fiscal Studies calculates that a third of key workers get less than the target rate for the national minimum wage.Singapore to Allow More Laborers to Resume Work (7:10 a.m. NY)Singapore will allow more construction laborers to return to work as the city-state looks to restart an economy that has been largely shut because of the coronavirus pandemic. The country will gradually add about 5% of the construction workforce, or about 20,000 workers, from June 2, on top of an existing 5% currently working on critical infrastructure projects.An outbreak among low-wage migrant workers staying in cramped dormitories has led Singapore to record one of the largest virus tallies in Asia. Of the nearly 27,000 total confirmed cases, about 90% are infections among workers in dormitories. Officials said this week that infection rates among this group are “stabilizing” and some 20,000 foreign workers will be ready for discharge from care facilities by the end of May.Cigarette Maker’s Vaccine Poised for Human Tests (6:58 a.m. NY)An experimental Covid-19 vaccine developed by cigarette maker British American Tobacco Plc is poised to begin testing in humans. Pre-clinical tests of the vaccine showed a positive immune response, the London-based tobacco company said Friday in a statement. The first phase of human trials could begin as soon as late June if authorized by drug regulators, BAT said.Drugmakers from around the world have jumped into the vaccine race, with more than 100 candidates in development in the U.S., Europe, China and other regions. BAT rival Philip Morris International Inc. is also testing an immunization. Smoking cigarettes, the two companies’ main products, may raise the risk of severe Covid symptoms, according to the World Health Organization.BAT subsidiary Kentucky BioProcessing uses tobacco plants in making the experimental vaccine, which is derived from the genetic sequence of Sars-CoV-2, the virus that causes Covid. According to BAT, the method generates the vaccine faster than conventional approaches, reducing the time required from several months to about six weeks.U.K. Northerners, Diabetics Among Most Vulnerable (6:33 a.m. NY)People in the North of England and diabetics are far more likely to die from coronavirus, data compiled by the U.K. national health service show. More than a quarter of all fatalities from Covid-19 were people with diabetes, according to the data, which for the first time breaks down deaths by underlying condition. In Northern England, 7,089 people died, nearly double the number of deaths in the South.Separate data from the Office for National Statistics show that more than 27% of care home deaths in England & Wales from March 2 through May 1 were linked to Covid-19. There were 73,180 deaths in the facilities from Dec. 28 to May 1, more than 23,000 above the same period a year earlier.E-Commerce Surge Boosts (6:02 a.m. NY) Inc. forecast a 20% to 30% rise in revenue, demonstrating how operating its own warehouses and delivery fleet is helping the e-commerce giant weather China’s economic slowdown. Revenue at China’s second largest online retailer rose a better-than-expected 21% in the March quarter. It forecast sales of between 180 billion yuan and 195 billion yuan this quarter, versus an average analyst estimate for 177.1 billion yuan.JD, which reported results before rivals Alibaba Group Holding Ltd. and Pinduoduo Inc., shows how China’s Covid-19 lockdown is pushing shoppers online, fueling an e-commerce boom. Investors expected JD to better endure the downturn thanks to a direct sales and in-house logistics model that helped it navigate supply disruptions. It’s gained $13 billion in market value since the novel coronavirus emerged in January.For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.

  • 7 Most Expensive Cigarette Brands in 2019
    Insider Monkey

    7 Most Expensive Cigarette Brands in 2019

    As smoking is becoming more of a taboo rather than a simple habit that it used to be, tobacco market is shrinking and companies are forced to improve their strategies in order to survive. Therefore, in today’s article we will research some of the most expensive cigarette brands in 2019. Smoking restriction laws are bringing […]

  • How Much Money Do You Need To Start Investing In Stocks?
    Investor's Business Daily

    How Much Money Do You Need To Start Investing In Stocks?

    Contrary to conventional wisdom, you don't need a hefty trust fund or deep pockets like mutual funds and other institutional players to start investing.

  • Tobacco giant BAT slides on report of U.S. criminal investigation

    Tobacco giant BAT slides on report of U.S. criminal investigation

    The world's second-biggest tobacco group on Tuesday said it was cooperating with the U.S. Department of Justice (DoJ) and Office of Foreign Assets Control (OFAC) without elaborating and declined to say whether the case was a criminal investigation. Neither the DoJ nor OFAC responded immediately to Reuters' requests for comment.

  • Reuters

    British American Tobacco under criminal probe by U.S. regulators - The Times

    Lucky Strike cigarette maker British American Tobacco is under criminal investigation by U.S. regulators over suspected sanctions-busting, The Times reported on Tuesday. The Department of Justice (DoJ) and the Office of Foreign Assets Control, a financial intelligence and enforcement agency that is part of the U.S. Treasury department, are investigating BAT for "suspicions of breach of sanctions", the newspaper reported, but said it is not clear which country or countries the regulators are focusing on.

  • BAT files patent suits against Philip Morris' IQOS products

    BAT files patent suits against Philip Morris' IQOS products

    The Lucky Strike cigarette maker said it had filed two patent infringement claims in the United States against Philip Morris, one through the International Trade Commission (ITC) and one in the Virginia federal court, seeking remedies for damages caused and an injunction on importing the product. The lawsuits in Germany and the United States focus on the heating blade technology used in IQOS, which BAT said was an earlier version of the technology currently being used in its glo tobacco heating devices.

  • Reuters

    CORRECTED-British American Tobacco files patent suits against Philip Morris' IQOS products

    British American Tobacco said on Thursday it had filed patent infringement challenges against Philip Morris International Inc in the United States, the UK and Germany over the heating technology used in its iQOS tobacco products. The Lucky Strike cigarette maker said it had brought two actions in the United States against Philip Morris, one through the International Trade Commission (ITC) and one in the district court of eastern Virginia that includes remedies for damages caused as well as an injunction. "If we win we may be able to get an ITC exclusion order blocking the importation of IQOS into the U.S. by Philip Morris unless they agree to take a license to our patents," Will Hill, spokesman for British American Tobacco, told Reuters.

  • British American Tobacco Unit to Develop Tobacco-Based Coronavirus Drug

    British American Tobacco Unit to Develop Tobacco-Based Coronavirus Drug

    British American Tobacco (BTI)  has said that its U.S. biotech unit is working on a potential plant-based vaccine for the treatment of the coronavirus using fast-growing tobacco plant technology.If pre-clinical testing goes well, Kentucky BioProcessing (KBP), the unit developing the vaccine, could produce between 1 million and 3 million doses a week starting in June, the company said, with support from government agencies and the right manufacturers.KBP, a division of British American Tobacco’s U.S. unit Reynolds American Inc, would develop the vaccine on a not-for-profit basis.The vaccine, currently undergoing pre-clinical testing, uses a cloned portion of COVID-19’s genetic sequence to develop an antigen that is then inserted into tobacco plants for reproduction. The antigen is a substance which induces an immune response in the body and in particular fosters the production of antibodies.Once the plants are harvested, the antigens are extracted and purified and inserted into the body to fight the virus, the company said. British American Tobacco added that tobacco plant technology has several advantages over conventional vaccine production technology. Plant-based technology is faster because the vaccine elements accumulate in 6 weeks in tobacco plants versus several months using conventional methods, the company said.“We believe we have made a significant break-through with our tobacco plant technology platform and stand ready to work with governments and all stakeholders to help win the war against COVID-19,” David O’Reilly, director of Scientific Research at BAT, said in a statement.Wall Street analyst Callum Elliott raised the company’s rating to Buy stating that in the eleven months since CEO Jack Bowles took over the business, the speed of change has been "impressive". The $50 average price target suggests a potential 38% upside in the share price in the next 12 months. (See British American Tobacco stock analysis on TipRanks)British American Tobacco said it was working with the U.S. Food and Drug Administration on the next steps and was also in discussions with U.K. health authorities to bring its vaccine to clinical studies as soon as possible.Related News: RedHill Biopharma Says First Coronavirus Patient Treated With Opaganib Drug 3 Healthcare Stocks Fighting the Coronavirus Incyte to Trial Cancer Drug for Patients with COVID-19 Associated Cytokine Storm More recent articles from Smarter Analyst: * Gilead Shares Rise On Early Peek At Positive Covid-19 Vaccine Data * Moderna Wins $483 Million US Government Award To Develop Coronavirus Vaccine * Roku Topped Estimates, but Uncertainty Lies Ahead * Starbucks Prepares to Gradually Reopen U.S. Cafes in May after Coronavirus Shutdown

  • Goldman Sachs Has a Point on Credit Recovery, But Be Very Careful

    Goldman Sachs Has a Point on Credit Recovery, But Be Very Careful

    (Bloomberg Opinion) -- With $250 billion of new U.S. bond issues at investment grade since the middle of March, and 150 billion euros ($164 billion) in Europe, the high-end credit market is an undoubted beneficiary of the central banks’ coronavirus stimulus plans. The debt capital market is definitely back open.Indeed, analysts at Goldman Sachs Group Inc. have bravely ventured that the worst of the widening of credit spreads — where the yield on corporate debt starts to increase faster than that of benchmark bonds — may be over for high-grade issuers.As I’ve written before, it’s important not to see this as a sign that all is well in the entirety of the credit markets: Companies with non-investment grade paper are crucial to the real economy too, but junk bonds are a long way from being in a good place. Defaults are looming.Setting aside the broader economic concerns of this state of affairs, there will be opportunities for investors in finding companies that will emerge from the crisis stronger — or the ones that will get most state support, if you’d prefer to be cynical. Credit selection, akin to stock-picking, will be the answer for those hunting yield. Tread carefully among the rubble and you might find some sparklers.As the Goldman analysts say, the high-grade part of the market is functioning well. There are 16 new issues slated in the euro debt capital markets on Thursday, including bonds from corporate giants such as BP Plc, British American Tobacco Plc and Royal Dutch Shell Plc. There’s even a rare deal coming in sterling, a market that’s been largely shut, from carmaker Volkswagen AG. That will be a significant test for a sector that’s been effectively shutdown by Covid-19.Credit spreads blew out spectacularly in March, and while things have improved, the environment has changed profoundly — even for the higher quality stuff. The premium offered on yields for new issues and overall credit spreads are significantly wider than during the first two months of this year, before the coronavirus struck the West in earnest. For corporate issuers, the heady days of rock-bottom interest rates are over, but this is better news for investors. The potential for positive performance is phenomenal, explaining why so many are diving back in to try to outperform the index. The European Central Bank has 1 trillion euros of bond purchases to complete this year, with as much as 20% of that to steer into eligible investment grade companies. That will be a major tailwind for a spike in the value of corporate debt.The ECB excludes financial firms and junk bonds from its Quantitative Easing program, but the crowded demand for high-quality paper will no doubt steer people toward non-investment grade sales, helping issuers. Also, whisper it, but the eligibility criteria for QE might well be softened.High-yield is still suffering badly from blown-out credit spreads. But it can offer the biggest opportunities to investors, especially if the particular company is critical to any economic recovery. Government credit and bailout plans might add to the appeal of certain sectors such as infrastructure, health and utilities. Less vital industries in the junk bond space will have to pay up to attract buyers. The beleaguered cruise liner company Carnival Corp had to pay a whopping 11.5% coupon to raise $4 billion this week. To get a sense of how far things have gone south for Carnival, at the beginning of March the yield on its existing three-year dollar bond had slipped below 2%. Bank debt might be popular too. Lenders’ senior investment-grade paper is already practically backstopped by national central banks. Subordinated bank debt remains for the brave, albeit the riskiest additional tier-1 perpetuals (known as CoCos, where investors lose out if a company goes bust) will always have their fans among those clamoring for proper yield. Selecting which companies can weather a crisis versus the dead ducks has probably been the most overlooked financial skill-set since the Lehman Brothers crisis, especially in corporate bonds. Blanket QE and the remorseless rise of passive investing has masked what active managers should be best at. It will pay in future to invest in a more selective fashion rather than simply buying the index.This column does not necessarily reflect the opinion of Bloomberg LP and its owners.Marcus Ashworth is a Bloomberg Opinion columnist covering European markets. He spent three decades in the banking industry, most recently as chief markets strategist at Haitong Securities in London.For more articles like this, please visit us at now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.


    5 Defensive Stocks Gurus Are Buying

    British American Tobacco tops the list Continue reading...

  • MarketWatch

    British American Tobacco says it is working on a potential vaccine for COVID-19

    British American Tobacco said a subsidiary, Kentucky BioProcessing, is working on a potential COVID-19 vaccine. The company said it is using tobacco plant technology and pre-clinical testing is under way. KBP recently cloned a portion of COVID-19's genetic sequence and inserted the antigen into tobacco plants. British American Tobacco said its work around the COVID-19 vaccine project will be carried out on a not-for-profit basis, and if testing goes well, could produce between 1 and 3 million doses per week, beginning in June, with partners.

  • Reuters

    British American Tobacco working on COVID-19 vaccine using tobacco leaves

    British American Tobacco, the maker of Dunhill and Lucky Strike cigarettes, said on Wednesday its U.S. biotech unit was working on a potential vaccine for COVID-19 using proteins extracted from tobacco leaves. Kentucky BioProcessing (KBP), the unit developing the vaccine, could produce between 1 million and 3 million doses per week starting in June, the company said, with support from government agencies and the right manufacturers. British American Tobacco said KBP, a division of BAT's U.S. unit Reynolds American Inc, would develop the vaccine on a not-for-profit basis.

  • British American Tobacco to Raise $2.4 Billion From Debt Offering

    British American Tobacco to Raise $2.4 Billion From Debt Offering

    British American Tobacco (BTI)  said on Tuesday it priced a debt offering of $2.4 billion notes and intends to use the proceeds for general business purposes, including paying off upcoming maturities.The maker of Lucky Strike and Dunhill cigarettes said it expected the issuance to close on April 2.“COVID-19 is developing rapidly. We are fortunate that our business is resilient and is supported by a geographically diversified supply chain from both a manufacturing and distribution standpoint,” British American Tobacco Chief Executive Officer Jack Bowles said on March 18. “As yet, we have seen no material impact.”With a Buy rating from two Wall Street analysts covering the company in the last three months, the stock is a Moderate Buy. The $50 average price target suggests a potential 51% upside in the share price in the next 12 months. (See British American Tobacco stock analysis on TipRanks)The joint book-running managers for the proposed offering are Capital Inc., BofA Securities, Inc., Citigroup Global Markets Inc., Mizuho Securities USA LLC and Santander Investment Securities Inc.Related News: Imperial Brands Sees No Coronavirus Impact, Secures New Loan Challenging Times Ahead for Boeing Stock; 5-Star Analyst Slashes Price Target Cytosorbents’ Blood Purification Technology Could Play Important Role in Fighting COVID-19; Analyst Says ‘Buy’ More recent articles from Smarter Analyst: * GE Shares Tumble On Analyst Downgrade, Reversing Earlier Gains * Caterpillar Looking For New $3 Billion Bank Loan * Shaw Communications Reports Strong Earnings, Branded ‘Safe Haven’ Stock By Top Analyst * Amazon Begins Building Covid-19 Testing Facility

  • Looks Like the Wrong Time to Quit Smoking

    Looks Like the Wrong Time to Quit Smoking

    (Bloomberg Opinion) -- Lloyd Bridges’s character in the disaster comedy “Airplane” captured it quite well when he said, “Looks like I picked the wrong week to quit smoking.” It’s a sentiment shared by people locked down around the world. While demand for most everything outside of food and toilet paper has declined, cigarettes are holding up.In an environment where companies are ditching their profit guidance left, right and center, Imperial Brands Plc, which makes Kool and Gauloises cigarettes, said on Tuesday that so far the virus had had no material impact on performance and trading remained in line with expectations. That echoes comments two weeks ago from British American Tobacco Plc. Shares in Imperial rose as much as 15%In the coronavirus-induced consumer crisis, big tobacco is certainly living up to its defensive reputation.After all, if people are addicted to nicotine, they still need their fix. And the pandemic-stricken world we live in provides incentives to light up more often:  Anxiety induced by ever-grimmer headlines; the fact that local stores selling cigarettes are still open; and the ease with which you can take a fag break when working from home as opposed to having to step outside the office.But it’s not unqualified good news for the industry.Imperial, which also makes Golden Virginia tobacco,  said that its factories were building contingency stocks, and its Logista distribution business serving Italy, France and Spain was doing the same to ensure supplies could get through to retailers. It’s also possible that as with rice and pasta, consumers are stockpiling cigarettes in case of even more stringent isolation measures down the road. So some demand may have been pulled forward, meaning this uptick might not be sustained in the long term.What’s more concerning is a recent focus on the increased risk of Covid-19 to smokers, and whether that may encourage more people to quit once the crisis has passed. Reports that the state of New York was in discussions about potentially banning cigarettes made headlines, but Bloomberg News reported on Monday that consideration of a ban was “100% not true.”Still, a renewed focus on personal health, especially where everyone’s lungs are concerned, would likely hurt cigarette sales in the future. These are all challenges tobacco companies will have to grapple with as they race to find what alternative product will drive growth if or when the world does kick its cigarette habit. The industry was already working to get past questions about health risks around vaping, which was last year linked with a spate of cases of respiratory illness. Groups including BAT, Altria Group Inc. and Philip Morris International Inc. have invested billions of dollars in electronic cigarettes and devices that heat rather than burn tobacco. Altria took a 35% stake in vaping leader Juul Labs Inc., which it has now written down. Right now, though, with the prospect of economic conditions deteriorating, tobacco’s resilience in the face of recession should come to the fore, especially given that traditional cigarettes remain the industry’s most profitable product. Smokers may trade down if money becomes tight, or switch to rolling their own cigarettes. But Duncan Fox, an analyst at Bloomberg Intelligence, says that even then pure tobacco has higher margins.So from a position a few months ago, where vaping sales were under pressure, but there were worries about an accelerated decline in smoking traditional cigarettes too, Big Tobacco’s core business now looks to be on a surer footing. That’s bad for public health, and for those funds that choose not to invest in cigarettes. But at least it can help preserve the industry’s profits and chunky dividend payouts for investors, when those at many other companies are suffering.This column does not necessarily reflect the opinion of Bloomberg LP and its owners.Andrea Felsted is a Bloomberg Opinion columnist covering the consumer and retail industries. She previously worked at the Financial Times.For more articles like this, please visit us at now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.

  • Those Who Purchased British American Tobacco (LON:BATS) Shares Three Years Ago Have A 52% Loss To Show For It
    Simply Wall St.

    Those Who Purchased British American Tobacco (LON:BATS) Shares Three Years Ago Have A 52% Loss To Show For It

    As an investor its worth striving to ensure your overall portfolio beats the market average. But its virtually certain...

  • British American Tobacco plc (BTI): Hedge Fund Sentiment Unchanged
    Insider Monkey

    British American Tobacco plc (BTI): Hedge Fund Sentiment Unchanged

    Coronavirus is probably the 1 concern in investors' minds right now. It should be. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW. We predicted that a US recession is imminent and US stocks will go down by at least 20% in the next 3-6 […]

  • Reuters

    South African unit of Philip Morris welcomes tax stance on cigarette alternatives

    The South African unit of cigarette maker Philip Morris International Inc welcomed the government's decision to introduce a lower excise tax on heated tobacco products than on regular cigarettes. In his annual budget speech on Wednesday, Minister of Finance Tito Mboweni said, in line with Department of Health policy, his government will start taxing heated tobacco products such as hookah or "hubbly bubbly". Electronic cigarettes, or so-called vapes, will only be taxed from 2021, Mboweni said.

  • Moody's

    B.A.T. International Finance p.l.c. -- Moody's affirms British American Tobacco's Baa2 ratings; outlook stable

    Moody's Investors Service, ("Moody's") has today affirmed the Baa2 long-term issuer rating of British American Tobacco p.l.c. Moody's also affirmed the P-2 short term ratings assigned to B.A.T. International Finance p.l.c., B.A.T Capital Corporation and the (P)Baa2 rating assigned to BAT's senior unsecured MTN programme.